Figure 1

INHα expression in clinical specimens and its association to prostate disease. Immunohistochemical staining of INHα in primary prostate tumours from PCa patients with (A–D) organ-confined (negative) and (E–H) metastatic disease (positive). INHα immunostaining intensity in benign epithelial, cancer region (G3/G4) and stromal regions (S) is shown. Inset shows IgG control. Bar=200 μm. B, D, F and H are enlargements of A, C, E and G, respectively.